Abstract
In Reply.— The letter by Olson and colleagues aptly points out that some instances of mushroom poisoning are caused by mixed mushroom ingestion and that early symptoms caused by mushrooms of low toxicity could mask later, more serious manifestations caused by amatoxins. This possibility again emphasizes that mushrooms involved in poisonings must be promptly and accurately identified and that the patient's fluid, electrolyte, and acid-base status requires careful monitoring until recovery is complete. We disagree that the use of thioctic acid and some other agents represents a grab bag approach to treatment of amatoxin poisoning and feel that their characterization of these therapies as antidotes is misleading. Our article stressed that intensive supportive care is the principal therapy for amatoxin poisoning and that the efficacy of thioctic acid has not been proved by controlled clinical trials. Nonetheless, numerous reports in the European and American literature, including an earlier report from
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
